Amarna Therapeutics Teaming Up with Austrian CBmed in the Development of Immunotherapies
01-Jul-2015 -
DutchAmarna Therapeutics announced that it has entered into a cooperation with Austrian Center for Biomarker Research in Medicine (CBmed), for the development of immunotherapies against acute lymphoblastic leukemia (ALL), obesity, diabetes mellitus type 2 (DM2) and atherosclerotic cardiovascular ...
acute lymphoblastic leukemia
atherosclerotic cardiovascular disease
biomarkers
+3